Literature DB >> 31660654

The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.

Sara Bandres-Ciga1,2, Sarah Ahmed1,3, Marya S Sabir1,3, Cornelis Blauwendraat1, Astrid D Adarmes-Gómez4,5, Inmaculada Bernal-Bernal4,5, Marta Bonilla-Toribio4,5, Dolores Buiza-Rueda4,5, Fátima Carrillo4,5, Mario Carrión-Claro4,5, Pilar Gómez-Garre4,5, Silvia Jesús4,5, Miguel A Labrador-Espinosa4,5, Daniel Macias4,5, Carlota Méndez-Del-Barrio4,5, Teresa Periñán-Tocino4,5, Cristina Tejera-Parrado4,5, Laura Vargas-González4,5, Monica Diez-Fairen6, Ignacio Alvarez6, Juan Pablo Tartari6, Mariateresa Buongiorno6, Miquel Aguilar6, Ana Gorostidi7,8,9, Jesús Alberto Bergareche7,8,10, Elisabet Mondragon7,8,10, Ana Vinagre-Aragon10, Ioana Croitoru7, Javier Ruiz-Martínez7,8,10, Oriol Dols-Icardo5,11, Jaime Kulisevsky5,12, Juan Marín-Lahoz5,12, Javier Pagonabarraga5,12, Berta Pascual-Sedano5,12, Mario Ezquerra5,13,14, Ana Cámara5,13,14, Yaroslau Compta5,13,14, Manel Fernández5,13,14, Rubén Fernández-Santiago5,13,14, Esteban Muñoz5,13,14, Eduard Tolosa5,13,14, Francesc Valldeoriola5,13,14, Isabel Gonzalez-Aramburu5,15, Antonio Sanchez Rodriguez5,15, María Sierra5,15, Manuel Menéndez-González16,17, Marta Blazquez16,17, Ciara Garcia16,17, Esther Suarez-San Martin16,17, Pedro García-Ruiz18, Juan Carlos Martínez-Castrillo19, Lydia Vela-Desojo20, Clara Ruz2,21, Francisco Javier Barrero2,22, Francisco Escamilla-Sevilla2,23, Adolfo Mínguez-Castellanos2,23, Debora Cerdan24, Cesar Tabernero24, Maria Jose Gomez Heredia25, Francisco Perez Errazquin25, Manolo Romero-Acebal25, Cici Feliz18, Jose Luis Lopez-Sendon19, Marina Mata26, Irene Martínez Torres27, Jonggeol Jeffrey Kim1, Clifton L Dalgard28,29, Janet Brooks1, Sara Saez-Atienzar30, J Raphael Gibbs31, Rafael Jorda32, Juan A Botia32,33, Luis Bonet-Ponce1, Karen E Morrison34, Carl Clarke35,36, Manuela Tan37, Huw Morris37, Connor Edsall1, Dena Hernandez1, Javier Simon-Sanchez38, Mike A Nalls1,39, Sonja W Scholz3,40, Adriano Jimenez-Escrig19, Jacinto Duarte24, Francisco Vives2,21, Raquel Duran2,21, Janet Hoenicka41,42, Victoria Alvarez17,43, Jon Infante5,15, Maria José Marti5,13,14, Jordi Clarimón5,11, Adolfo López de Munain7,8,44, Pau Pastor6, Pablo Mir4,5, Andrew Singleton1.   

Abstract

BACKGROUND: The Iberian Peninsula stands out as having variable levels of population admixture and isolation, making Spain an interesting setting for studying the genetic architecture of neurodegenerative diseases.
OBJECTIVES: To perform the largest PD genome-wide association study restricted to a single country.
METHODS: We performed a GWAS for both risk of PD and age at onset in 7,849 Spanish individuals. Further analyses included population-specific risk haplotype assessments, polygenic risk scoring through machine learning, Mendelian randomization of expression, and methylation data to gain insight into disease-associated loci, heritability estimates, genetic correlations, and burden analyses.
RESULTS: We identified a novel population-specific genome-wide association study signal at PARK2 associated with age at onset, which was likely dependent on the c.155delA mutation. We replicated four genome-wide independent signals associated with PD risk, including SNCA, LRRK2, KANSL1/MAPT, and HLA-DQB1. A significant trend for smaller risk haplotypes at known loci was found compared to similar studies of non-Spanish origin. Seventeen PD-related genes showed functional consequence by two-sample Mendelian randomization in expression and methylation data sets. Long runs of homozygosity at 28 known genes/loci were found to be enriched in cases versus controls.
CONCLUSIONS: Our data demonstrate the utility of the Spanish risk haplotype substructure for future fine-mapping efforts, showing how leveraging unique and diverse population histories can benefit genetic studies of complex diseases. The present study points to PARK2 as a major hallmark of PD etiology in Spain.
© 2019 International Parkinson and Movement Disorder Society. © 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; Spanish population; age at onset; polygenic risk score; risk haplotype

Mesh:

Substances:

Year:  2019        PMID: 31660654      PMCID: PMC8393828          DOI: 10.1002/mds.27864

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  40 in total

1.  Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene.

Authors:  P Pastor; E Pastor; C Carnero; R Vela; T García; G Amer; E Tolosa; R Oliva
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

2.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

3.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.

Authors:  Suzanne Lesage; Alexandra Dürr; Meriem Tazir; Ebba Lohmann; Anne-Louise Leutenegger; Sabine Janin; Pierre Pollak; Alexis Brice
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

4.  Analysis of the genetic variability in Parkinson's disease from Southern Spain.

Authors:  Sara Bandrés-Ciga; Niccolò Emmanuele Mencacci; Raquel Durán; Francisco Javier Barrero; Francisco Escamilla-Sevilla; Sarah Morgan; Jason Hehir; Francisco Vives; John Hardy; Alan M Pittman
Journal:  Neurobiol Aging       Date:  2015-10-08       Impact factor: 4.673

5.  Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets.

Authors:  Zhihong Zhu; Futao Zhang; Han Hu; Andrew Bakshi; Matthew R Robinson; Joseph E Powell; Grant W Montgomery; Michael E Goddard; Naomi R Wray; Peter M Visscher; Jian Yang
Journal:  Nat Genet       Date:  2016-03-28       Impact factor: 38.330

Review 6.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

7.  Relative high frequency of the c.255delA parkin gene mutation in Spanish patients with autosomal recessive parkinsonism.

Authors:  E Muñoz; E Tolosa; P Pastor; M J Martí; F Valldeoriola; J Campdelacreu; R Oliva
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

8.  PRSice: Polygenic Risk Score software.

Authors:  Jack Euesden; Cathryn M Lewis; Paul F O'Reilly
Journal:  Bioinformatics       Date:  2014-12-29       Impact factor: 6.937

9.  Detecting structure of haplotypes and local ancestry.

Authors:  Yongtao Guan
Journal:  Genetics       Date:  2014-01-03       Impact factor: 4.562

10.  Systematic identification of trans eQTLs as putative drivers of known disease associations.

Authors:  Harm-Jan Westra; Marjolein J Peters; Tõnu Esko; Hanieh Yaghootkar; Claudia Schurmann; Johannes Kettunen; Mark W Christiansen; Bruce M Psaty; Samuli Ripatti; Alexander Teumer; Timothy M Frayling; Andres Metspalu; Joyce B J van Meurs; Lude Franke; Benjamin P Fairfax; Katharina Schramm; Joseph E Powell; Alexandra Zhernakova; Daria V Zhernakova; Jan H Veldink; Leonard H Van den Berg; Juha Karjalainen; Sebo Withoff; André G Uitterlinden; Albert Hofman; Fernando Rivadeneira; Peter A C 't Hoen; Eva Reinmaa; Krista Fischer; Mari Nelis; Lili Milani; David Melzer; Luigi Ferrucci; Andrew B Singleton; Dena G Hernandez; Michael A Nalls; Georg Homuth; Matthias Nauck; Dörte Radke; Uwe Völker; Markus Perola; Veikko Salomaa; Jennifer Brody; Astrid Suchy-Dicey; Sina A Gharib; Daniel A Enquobahrie; Thomas Lumley; Grant W Montgomery; Seiko Makino; Holger Prokisch; Christian Herder; Michael Roden; Harald Grallert; Thomas Meitinger; Konstantin Strauch; Yang Li; Ritsert C Jansen; Peter M Visscher; Julian C Knight
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

View more
  19 in total

Review 1.  Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.

Authors:  Sara Bandres-Ciga; Monica Diez-Fairen; Jonggeol Jeff Kim; Andrew B Singleton
Journal:  Neurobiol Dis       Date:  2020-01-25       Impact factor: 5.996

2.  Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.

Authors:  William Zhu; Xiaoping Huang; Esther Yoon; Sara Bandres-Ciga; Cornelis Blauwendraat; Kimberly J Billingsley; Joshua H Cade; Beverly P Wu; Victoria H Williams; Alice B Schindler; Janet Brooks; J Raphael Gibbs; Dena G Hernandez; Debra Ehrlich; Andrew B Singleton; Derek P Narendra
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

3.  17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson's disease are associated with LRRC37A/2 expression in astrocytes.

Authors:  Kathryn R Bowles; Derian A Pugh; Yiyuan Liu; Tulsi Patel; Alan E Renton; Sara Bandres-Ciga; Ziv Gan-Or; Peter Heutink; Ari Siitonen; Sarah Bertelsen; Jonathan D Cherry; Celeste M Karch; Steven J Frucht; Brian H Kopell; Inga Peter; Y J Park; Alexander Charney; Towfique Raj; John F Crary; A M Goate
Journal:  Mol Neurodegener       Date:  2022-07-15       Impact factor: 18.879

4.  The Big Picture of Neurodegeneration: A Meta Study to Extract the Essential Evidence on Neurodegenerative Diseases in a Network-Based Approach.

Authors:  Nicolas Ruffini; Susanne Klingenberg; Raoul Heese; Susann Schweiger; Susanne Gerber
Journal:  Front Aging Neurosci       Date:  2022-06-27       Impact factor: 5.702

5.  Longitudinal intronic RNA-Seq analysis of Parkinson's disease patients reveals disease-specific nascent transcription.

Authors:  Sulev Koks; Abigail L Pfaff; Vivien J Bubb; John P Quinn
Journal:  Exp Biol Med (Maywood)       Date:  2022-03-15

Review 6.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

7.  Reassessment of candidate gene studies for idiopathic restless legs syndrome in a large genome-wide association study dataset of European ancestry.

Authors:  Barbara Schormair; Chen Zhao; Aaro V Salminen; Konrad Oexle; Juliane Winkelmann
Journal:  Sleep       Date:  2022-08-11       Impact factor: 6.313

8.  Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next Steps.

Authors: 
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

9.  Effect of plasma vitamin C levels on Parkinson's disease and age at onset: a Mendelian randomization study.

Authors:  Haijie Liu; Yan Zhang; Haihua Zhang; Longcai Wang; Tao Wang; Zhifa Han; Liyong Wu; Guiyou Liu
Journal:  J Transl Med       Date:  2021-05-24       Impact factor: 5.531

10.  Imputation and Reanalysis of ExomeChip Data Identifies Novel, Conditional and Joint Genetic Effects on Parkinson's Disease Risk.

Authors:  Linduni M Rodrigo; Dale R Nyholt
Journal:  Genes (Basel)       Date:  2021-05-04       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.